Sign up to save your podcasts
Or
Share "The Future of ALS Clinical Trials…"
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
"The Future of ALS Clinical Trials…"
On this week’s episode, Mike and Jeremy talk to Dr. Merit Cudkowicz, chief of neurology at Massachusetts General Hospital and director of the Sean M. Healey & AMG Center for ALS, about the impact of COVID-19 on conducting clinical trials. Dr. Cudkowicz also provides an update on the Healey Platform Trial and potential long-term changes to trial design.
To learn more about Dr. Cudkowicz, go to https://www.massgeneral.org/doctors/16904/merit-cudkowicz
Read all about the Healey Platform Trial at https://alsadotorg.wordpress.com/2020/01/17/in-case-you-missed-it-the-als-association-invests-3-million-in-first-ever-als-platform-trial-to-speed-up-clinical-trial-process/
This episode was produced by Garrett Tiedemann and is brought to you by The ALS Association’s national office and the Association’s Minnesota/North Dakota/South Dakota Chapter.
View all episodes
By ALS Association
4.7
4949 ratings
On this week’s episode, Mike and Jeremy talk to Dr. Merit Cudkowicz, chief of neurology at Massachusetts General Hospital and director of the Sean M. Healey & AMG Center for ALS, about the impact of COVID-19 on conducting clinical trials. Dr. Cudkowicz also provides an update on the Healey Platform Trial and potential long-term changes to trial design.
To learn more about Dr. Cudkowicz, go to https://www.massgeneral.org/doctors/16904/merit-cudkowicz
Read all about the Healey Platform Trial at https://alsadotorg.wordpress.com/2020/01/17/in-case-you-missed-it-the-als-association-invests-3-million-in-first-ever-als-platform-trial-to-speed-up-clinical-trial-process/
This episode was produced by Garrett Tiedemann and is brought to you by The ALS Association’s national office and the Association’s Minnesota/North Dakota/South Dakota Chapter.